The right Timing, right combination, right sequence, and right delivery for Cancer immunotherapy

Volume: 331, Pages: 321 - 334
Published: Mar 1, 2021
Abstract
Cancer immunotherapy (CI) represented by immune checkpoint inhibitors (ICIs) presents a new paradigm for cancer treatment. However, the types of cancer that attain a therapeutic benefit from ICIs are limited, and the efficacy of these treatments does not meet expectations. To date, research on ICIs has mainly focused on identifying biomarkers and patient characteristics that can enhance the therapeutic effect on tumors. However, studies on...
Paper Details
Title
The right Timing, right combination, right sequence, and right delivery for Cancer immunotherapy
Published Date
Mar 1, 2021
Volume
331
Pages
321 - 334
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.